AAO Decisions Explorer · Free
Published AAO appeal decisions
Search the decisions the Administrative Appeals Office has published, narrow them by visa, criterion, field and year, and read our summary of each one with a link to the official PDF.

Decisions in the library
6,586
6,586 classified
Visa types
3
Years covered
2005-2026
Latest decision
Aug 31, 2026
Filters
34 decisions
Outcomes in these results
- Dismissed
- Remanded
- Sustained
- EB-2 NIWBiotech and pharmaJun 2026Dismissed
A biomedical scientist and biotechnology executive with experience in molecular biology and clinical diagnostics proposed to establish a venture consulting practice for early-stage biotech companies. The AAO dismissed the appeal because the petitioner failed to demonstrate the proposed endeavor's national importance; the record showed only individualized client services without broader field-wide impact.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJun 2026Dismissed
Chemical and biomedical engineer with Ph.D. sought EB-2 classification and NIW. Petitioner established first prong of substantial merit and national importance of proposed research endeavor. AAO agreed but found petitioner did not sufficiently demonstrate record of success in related efforts, citations impact, or viable plan with documentary support for claimed employment.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaFeb 2026Dismissed
Postdoctoral researcher with advanced degrees seeks NIW for CAR T cell research involving epigenetic reprogramming. AAO found endeavor meets national importance but failed to demonstrate she is well positioned to advance it despite citations and peer review participation.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaFeb 2026Dismissed
Formulation scientist with Ph.D. seeks NIW for drug delivery systems research. AAO found substantial merit and national importance of proposed research endeavor but concluded petitioner failed to demonstrate independence from employer, failing second prong.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJan 2026Dismissed
A graduate student in biomedical engineering seeks NIW for research on photoacoustic imaging in clinical settings. The AAO found the endeavor has substantial merit and national importance but dismissed because the petitioner did not demonstrate she is well-positioned to advance it, lacking a Ph.D., documented employment, or evidence of progress or investor interest.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharma2026Dismissed
Biomechanical engineer and researcher claiming NIW for EB-2 with proposed endeavor in cell therapy and biomaterials. Substantial merit found but national importance not established; prospective impact not attributed to petitioner or shown to have prospective economic effect. Appeal dismissed.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaDec 2025Remanded
Biochemistry graduate student seeks NIW waiver for antibiotic resistance research endeavor. Service center denied waiver, finding advanced degree established but national importance and waiver benefit not shown. AAO remanded for fuller analysis of Dhanasar prongs, noting service center overlooked expert letters and inadequately addressed evidence.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaDec 2025Dismissed
Biomedical researcher seeks EB-2 with national interest waiver. AAO found proposed research endeavor has substantial merit and national importance but concluded petitioner lacks adequate credentials, publications, and documented education to be well positioned to advance it. Appeal dismissed on second prong failure.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaNov 2025Dismissed
Clinical laboratory scientist proposes AI forecasting models to address blood-bank shortages. AAO held endeavor has national importance but petitioner not well positioned to advance it: lacks demonstrated AI capabilities, formal machine learning education, and progress evidence despite prior statistics coursework and media attention.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJul 2025Dismissed
Postdoctoral fellow in biomedical research sought EB-2 NIW with advanced degree. Proposed cancer research endeavor met substantial merit and national importance, but AAO found petitioner not well positioned to advance it: lacking significant funded grant record, evidence of work adoption by others, or comprehensive future plan despite strong academic credentials.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJun 2025Dismissed
A medical scientist sought EB-2 classification with national interest waiver for a biomedical research and clinical diagnostics endeavor. The AAO affirmed dismissal, holding the petitioner failed to demonstrate national importance under Dhanasar's first prong, showing only individualized benefits to clients and employees rather than broader field or regional impact.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJun 2025Dismissed
Biomedical scientist with Ph.D. sought NIW for postdoctoral research on nanomembranes for cancer treatment. AAO found substantial merit and national importance but dismissed appeal because petitioner failed to demonstrate she was well-positioned to advance the endeavor through lack of sustained funding, clear research plan, or stakeholder interest.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMay 2025Dismissed
Biomedical scientist sought EB-2 with national interest waiver for genetic research on medical conditions. AAO found petitioner failed to establish advanced degree eligibility due to translation deficiencies and did not demonstrate national importance of proposed endeavor, lacking specific prospective impact evidence.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaApr 2025Dismissed
A biomedical researcher with a PhD in immunology sought EB-2 NIW classification for research on genome and protein engineering. The AAO agreed he met EB-2 requirements but found his specific proposed endeavor lacked national importance despite involving critical emerging technologies, as expert letters discussed his field generally, not his particular research.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMar 2025Dismissed
Medical scientist seeking EB-2 NIW for cancer research endeavor. Claimed substantial merit and national importance through publications, recommendations, and funding. AAO held proposed work lacks demonstrated national importance because specific endeavor's broader field implications were not established; general cancer information insufficient.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMar 2025Dismissed
Biomedical systems technician seeks NIW to establish business providing clinical engineering services, equipment maintenance, and training. AAO dismissed appeal, finding the petitioner failed to demonstrate national importance of the proposed endeavor, lacking evidence of substantial economic impact, job creation, or industry-wide implications beyond prospective clients.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaFeb 2025Dismissed
A biomedical scientist and clinical pathology technician sought EB-2 with national interest waiver. The AAO dismissed the appeal, holding that the proposed biomedical company's services and training would not extend beyond individual clients to have national importance or broader field impact.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaFeb 2025Dismissed
Pharmaceutical sales representative with advanced degree seeks EB-2 national interest waiver for health-related project. Petitioner claimed national importance through health and economic benefits. AAO held substantial merit shown but national importance unmet; endeavor lacks evidence of broader field or regional impact exceeding specific occupational role.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaDec 2024Sustained
A physician-researcher pursuing a Ph.D. in biomedical sciences seeks NIW for research on breast cancer biomarkers and early detection. The petitioner claimed three Dhanasar prongs. The AAO sustained the appeal, finding the proposed research has substantial merit and national importance, the petitioner is well-positioned to advance it given his medical degree and publication record, and waiving job offer requirements would benefit the United States.
3 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaNov 2024Dismissed
Biomedical engineer researcher proposed postdoctoral research on brain cognitive processes using machine learning. AAO withdrew denial of prong one, finding national importance, but affirmed denial under prong two because petitioner lacked demonstrated influence or record of success advancing the field.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaAug 2024Dismissed
A bioengineer and prosthetics researcher sought EB-2 classification with a national interest waiver. The AAO dismissed the appeal, finding she failed to establish a U.S. bachelor's or advanced degree equivalent and, even under exceptional ability, did not meet three evidentiary criteria. The proposed endeavor lacked specific evidence of national importance.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaAug 2024Dismissed
Bioanalyst and high school teacher seeking NIW for consulting business in bioanalysis and STEM education. Claimed endeavor would advance science education and economic growth. AAO dismissed appeal, finding proposed endeavor lacked national importance and petitioner not well-positioned to advance it.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaApr 2024Dismissed
Pharmacist and entrepreneur sought NIW to operate business providing parenteral nutrition products. AAO affirmed denial, finding petitioner failed to describe proposed endeavor with sufficient specificity and provide corroborating evidence that business activities would achieve substantial national economic impact.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMar 2024Dismissed
Bioengineering technology researcher seeking NIW for EB-2. AAO agreed endeavor has national importance but held she is not well-positioned to advance it because her research lacks substantial citations, field impact, and evidence of obtaining funding, failing the second Dhanasar prong.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaFeb 2024Dismissed
Pharmaceutical professional seeking EB-2 exceptional ability classification and national interest waiver. AAO dismissed appeal because petitioner failed to meet three initial evidentiary criteria for exceptional ability and did not establish specific endeavor or its prospective national importance under Dhanasar framework.
0 of 3 criteria metRead →
